NEW YORK (GenomeWeb News) – Danaher said today that its revenues in the fourth quarter rose 6 percent year over year with its Life Sciences & Diagnostics segment leading the way.

For the three months ended Dec. 31, 2013, the company posted revenues of $5.27 billion, up from $4.98 billion in Q4 2012, and beating the consensus Wall Street estimate of $5.20 billion.

Danaher's profit for the quarter was up to $789.3 million, or $1.11 per share, from $630.4 million, or $0.89 per share, in Q4 2012, besting analyst estimates of $0.95 per share.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

China is embracing preimplantation genetic diagnosis, Nature News reports. 

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.

Oct
10
Sponsored by
PerkinElmer

This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.